Abstract
Placental site trophoblastic tumour (PSTT) is a rarest type of gestational trophoblastic disease (GTD) with an incidence of 1/50,000–100,000 of all pregnancies. In contrary to other variants of GTD, it arises from the intermediate trophoblast at placental site, secretes minimal beta-hCG and very less sensitivity for chemotherapeutic agents. Patient presents with amenorrhoea and abnormal bleeding. Imaging modalities like ultrasonography and MRI helps in making the diagnosis but is conrmed after histological evaluation and immunohistochemistry (IHC) studies. Patients mostly present with tumour limited to the uterine body. The mainstay of treatment is total hysterectomy. The prognosis of patients with tumour limited to the uterus is good
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
